• By ICR Secretariat
  • Posted Thursday, September 8, 2022

Pfizer shifts oncology chief Schmeltz to new strategy role as rare disease head Varma fills in

https://www.fiercepharma.com/executives/pfizer-executives-move-new-positions-within-company

Executive reshuffling continues at Pfizer.

After four years as global president of Pfizer oncology, Andy Schmeltz is moving into a new role as senior vice president of commercial strategy and innovation, the 19-year Pfizer veteran announced in a  LinkedIn post.